Evidence map›Paper›PMID 36530899›Full record

ArticleFrontiers in medicine2022

Predicting oxygen requirements in patients with coronavirus disease 2019 using an artificial intelligence-clinician model based on local non-image data.

Reiko Muto, Shigeki Fukuta, Tetsuo Watanabe, Yuichiro Shindo, Yoshihiro Kanemitsu, Shigehisa Kajikawa, Toshiyuki Yonezawa, Takahiro Inoue, Takuji Ichihashi, Yoshimune Shiratori and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Reiko MutoDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Shigeki FukutaArtificial Intelligence Laboratory, Fujitsu Limited, Kawasaki, Japan.
Tetsuo WatanabeDX Platform Business Unit, Fujitsu Limited, Nagoya, Japan.
Yuichiro ShindoDepartment of Internal Medicine, Aichi Prefectural Aichi Hospital, Okazaki, Japan.
Yoshihiro KanemitsuDepartment of Internal Medicine, Aichi Prefectural Aichi Hospital, Okazaki, Japan.
Shigehisa KajikawaDepartment of Internal Medicine, Aichi Prefectural Aichi Hospital, Okazaki, Japan.
Toshiyuki YonezawaDepartment of Internal Medicine, Aichi Prefectural Aichi Hospital, Okazaki, Japan.
Takahiro InoueDepartment of Internal Medicine, Aichi Prefectural Aichi Hospital, Okazaki, Japan.
Takuji IchihashiDepartment of Internal Medicine, Aichi Prefectural Aichi Hospital, Okazaki, Japan.
Yoshimune ShiratoriCenter for Healthcare Information Technology (C-HiT), Nagoya University, Nagoya, Japan.
Shoichi MaruyamaDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nagoya University · JPAichi Medical University Hospital · JPFujitsu (Japan) · JPFujita Health University · JPNagoya City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: When facing unprecedented emergencies such as the coronavirus disease 2019 (COVID-19) pandemic, a predictive artificial intelligence (AI) model with real-time customized designs can be helpful for clinical decision-making support in constantly changing environments. We created models and compared the performance of AI in collaboration with a clinician and that of AI alone to predict the need for supplemental oxygen based on local, non-image data of patients with COVID-19. Materials and methods: We enrolled 30 patients with COVID-19 who were aged >60 years on admission and not treated with oxygen therapy between December 1, 2020 and January 4, 2021 in this 50-bed, single-center retrospective cohort study. The outcome was requirement for oxygen after admission. Results: The model performance to predict the need for oxygen by AI in collaboration with a clinician was better than that by AI alone. Sodium chloride difference >33.5 emerged as a novel indicator to predict the need for oxygen in patients with COVID-19. To prevent severe COVID-19 in older patients, dehydration compensation may be considered in pre-hospitalization care. Conclusion: In clinical practice, our approach enables the building of a better predictive model with prompt clinician feedback even in new scenarios. These can be applied not only to current and future pandemic situations but also to other diseases within the healthcare system.

Indexed as

artificial intelligence-human collaborationclinical practiceCOVID-19oxygen needssodium chloride difference

Identifiers

PMID36530899
PMCPMC9748157
OpenAlexW4311046879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.